2023
DOI: 10.1164/rccm.202210-1953ed
|View full text |Cite
|
Sign up to set email alerts
|

Gastroesophageal Reflux, Atopic Dermatitis, and Asthma: Finally Evidence for Causal Links?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 15 publications
0
3
0
Order By: Relevance
“…GERD is common among people with asthma and can worsen and trigger asthma attacks. Treating GERD improves the respiratory symptoms of asthma patients [ 40 ]. Possible GERD–asthma symptoms include reflux-related respiratory issues, worsened asthma after meals or lying down, nocturnal asthma, and poor responses to bronchodilators [ 41 ].…”
Section: Gerd Overviewmentioning
confidence: 99%
“…GERD is common among people with asthma and can worsen and trigger asthma attacks. Treating GERD improves the respiratory symptoms of asthma patients [ 40 ]. Possible GERD–asthma symptoms include reflux-related respiratory issues, worsened asthma after meals or lying down, nocturnal asthma, and poor responses to bronchodilators [ 41 ].…”
Section: Gerd Overviewmentioning
confidence: 99%
“…Among the instrumental variables (IVs) representing gastrointestinal diseases, SNPs related to smoking, asthma, and lung function will be excluded. Previous research has also indicated an increased risk of gastrointestinal diseases with asthma (Althoff and Sharma, 2023), and both gastrointestinal diseases and COPD are susceptible to the influence of smoking (Berkowitz et al, 2018;Maret-Ouda et al, 2020b). Therefore, when selecting IVs for COPD, SNPs related to smoking and asthma will be excluded.…”
Section: Instrumental Variablesmentioning
confidence: 99%
“… 121 Although GERD and DA are associated, its precise processes are yet unknown. 122 The effect of GERD medication on asthma outcomes in both adults and children is still debatable. The addition of lansoprazole, a proton-pump inhibitor, as compared to a placebo, did not improve symptoms or lung function in children with poorly controlled asthma who were using ICS but was associated with an increase in adverse events.…”
Section: Evaluation and Management Of Damentioning
confidence: 99%